SCHEDULE 13G/A: BlackRock Discloses 14.7% Passive Stake in Owens & Minor Inc.

BlackRock, Inc. has filed an updated Schedule 13G, revealing a passive beneficial ownership of 14.7% in Owens & Minor Inc.'s common stock as of March 31, 2025.

Summary

• BlackRock, Inc. reported beneficial ownership of 11,337,042 shares of Owens & Minor Inc. common stock.
• This ownership represents 14.7% of the total outstanding common stock of Owens & Minor Inc.
• BlackRock holds sole voting power over 11,209,967 shares and sole dispositive power over 11,337,042 shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
• Certain BlackRock business units, including BlackRock Fund Advisors and iShares Core S&P Small-Cap ETF, are noted to beneficially own 5% or greater of the outstanding shares.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of an ownership stake, indicating a neutral sentiment. It neither presents overwhelmingly positive nor negative news about the issuer's performance, but rather the investor's position.

Positives

• BlackRock's significant 14.7% stake indicates a substantial institutional investment in Owens & Minor Inc., potentially signaling confidence in the company's long-term prospects.
• The filing explicitly states that the shares are held in the ordinary course of business and not for control, which suggests a stable, passive investment rather than an activist position that could introduce volatility.

Risks

• The document does not detail specific risks related to Owens & Minor Inc.'s operations or financial health, as it is a disclosure of ownership by an institutional investor.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance regarding Owens & Minor Inc.'s future performance or BlackRock's future investment intentions beyond the passive nature of the current holding.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11." (Certification by Spencer Fleming, Managing Director of BlackRock, Inc.)

Industry Context

This filing is a routine disclosure by a major institutional investor, BlackRock, Inc., regarding its significant passive stake in Owens & Minor Inc., a company operating in the healthcare distribution and medical supplies industry. Such large passive holdings by asset managers like BlackRock are common across various industries, reflecting their broad market exposure through index funds and other investment vehicles.

Comparison to Industry Standards

• As a Schedule 13G filing, this document primarily serves as a disclosure of ownership and does not provide performance metrics for comparison to industry standards. It details BlackRock's stake in Owens & Minor Inc., a healthcare solutions company, which operates in a competitive market alongside peers such as Cardinal Health, McKesson, and Medline. The 14.7% stake is a substantial passive holding for an institutional investor in a publicly traded company of this size.

Stakeholder Impact

• Shareholders: BlackRock's significant passive stake may be viewed positively by other shareholders as it indicates a large, stable institutional investor's confidence in the company, potentially contributing to share price stability.
• Management: The certification that the stake is not for control purposes suggests that BlackRock is not seeking to influence management or corporate strategy, which could provide stability for the current leadership.

Key Dates

Keywords

BlackRock, Owens & Minor, OM, Schedule 13G, Institutional Ownership, Common Stock, Beneficial Ownership, Passive Investment, Healthcare Distribution, Medical Supplies